#liquid-biopsy
#liquid-biopsy

[ follow ]

Rafael Lopez, oncologist: With a blood test we expect to be able to identify the weaknesses of almost all tumors'

Liquid biopsy technology is revolutionizing cancer treatment by enabling earlier detection and better prognostication.

OXcan has raised $11M for developing next-gen blood tests aimed at early lung cancer detection.

Dr. Heinrich Roder has been appointed SVP of Research & Development, bringing extensive expertise in cancer diagnostics.

[ Load more ]